Lanean...
Barriers to Hepatitis C Direct-acting Antiviral Therapy among HIV/HCV-Coinfected Persons
BACKGROUND AND AIM: Direct-acting antivirals (DAAs) have increased HCV treatment opportunities for vulnerable HIV/HCV coinfected persons. The aim of this study was to identify the frequency of and potential barriers to DAA prescription in HIV/HCV patients during the first few years of DAA availabili...
Gorde:
| Argitaratua izan da: | J Gastroenterol Hepatol |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904967/ https://ncbi.nlm.nih.gov/pubmed/32840904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.15228 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|